Expression analysis of miRNA-155 level in Helicobacter pylori related inflammation and chronic gastritis

Ramina Mahboobi1, Fatemeh Fallah1,2, Abbas Yadegar3

  • 1Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abstract

Insights

MicroRNA-155 (miRNA-155) expression significantly increases in the serum and gastric tissue of adults with chronic gastritis due to Helicobacter pylori infection. This elevated miRNA-155 shows potential as a diagnostic marker for gastritis.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Oncology

Background:

  • Helicobacter pylori infection is a primary cause of gastritis and is linked to gastrointestinal diseases.
  • Noncoding microRNAs (miRNAs) are increasingly recognized for their role in inflammation and malignancy.
  • MiRNA-155 is implicated in inflammation control and gastric cancer development.

Purpose of the Study:

  • To compare miRNA-155 expression in gastric biopsy and serum samples of adult patients with chronic gastritis.
  • To investigate the potential of miRNA-155 as a prognostic marker for gastric cancer in chronic gastritis.
  • To assess the relationship between miRNA-155 expression and H. pylori virulence factors.

Main Methods:

  • Collected gastric biopsy and blood samples from H. pylori-infected adults and a control group.
  • Detected H. pylori infection using histology, culture, and PCR, with genotyping for CagA and VacA.
  • Quantified miRNA-155 expression using real-time RT-PCR in tissue and serum samples.

Main Results:

  • Significantly higher miRNA-155 expression (5.61-fold in serum, 10.11-fold in tissue) was observed in H. pylori-infected patients compared to controls.
  • The increased miRNA-155 expression was independent of CagA and VacA toxins.
  • Differential expression patterns of miRNA-155 were noted in serum samples.

Conclusions:

  • MiRNA-155 expression is significantly elevated in adult patients with H. pylori-induced chronic gastritis.
  • Serum miRNA-155 demonstrates potential as a reliable biomarker for diagnosing chronic gastritis.
  • Further research may validate miRNA-155 as a prognostic indicator for gastric cancer.